FTFranklin Templeton MFGrowth

Franklin Pharma Fund - Growth

Pharma & Health CareEquity - Sectoral Fund - Pharma & Health CareBenchmark: ET Pharma
NAV · 09 Sep 2011₹61.62-0.40%
AUM₹134 Cr
Expense Ratio2.06%
CAGR
Exit Load1% on or before 1Y
Min SIP₹500
Launched1999

Investment Objective

The scheme seeks to provide long-term capital appreciation by investing primarily in Pharmaceutical stocks, biotechnology and agrochemicals with high profit potential.

Fund Mandate

Debt0%–35%
Equity65%–100%
MMI0%–35%
Others0%–35%
Asset Allocation
Domestic Equity79.8%
Debt0.2%
Cash & Equivalents20.0%
Fund Managers
AR
Anand Radhakrishnan
Fund Manager
Key Information
2.06%
₹500
₹5,000
1% on or before 1Y
Nil
Inception31 Mar 1999
AMCFranklin Templeton MF
Top Holdings
1Call, Cash & Other Current Assets 19.99%
2Cadila Healthcare *10.63%
3Dr. Reddy's *9.04%
4Lupin Labs *8.57%
5IPCA Labs *7.04%
6Pfizer *6.68%
7Wyeth *6.33%
8Torrent Pharmaceuticals *5.82%
9Sun Pharmaceutical *5.49%
10Apollo Hospitals Enterprise *4.59%
Sector Allocation
Other79.8%
20.0%
Trailing Returns
PeriodReturns
1 Day-0.40%
Risk Metrics

Risk metrics are not available for this fund.

Fees
2.06%
1% on or before 1Y
Nil
₹500
₹5,000
Capital Gains Tax, general rules

This is an equity-oriented fund. Under rules effective since Budget 2024 (23 July 2024):

Short-Term Capital Gains (held ≤ 12 months): taxed at a flat 20%.

Long-Term Capital Gains (held > 12 months): taxed at 12.5% on gains above ₹1.25 lakh in a financial year, with no indexation benefit.

General information only, not tax advice, actual liability depends on your overall income and applicable law at the time of redemption. Consult a tax advisor for your specific situation.

Frequently Asked QuestionsGeneral mutual-fund FAQs, not specific to this scheme